| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Technology Officer | Chief Technology Officer
1 company
Harmon Cyrus is a Director at Olema Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $11.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2024 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 20,000 | $10.97 | $219,400.00 | -2.4% | -2.3% | -63.7% | |
| Feb 29, 2024 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 25,000 | $12.41 | $310,309.00 | -1.5% | -22.2% | -64.8% | |
| Feb 1, 2024 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 30,000 | $12.79 | $383,550.00 | -1.7% | -31.8% | -59.9% | |
| Dec 29, 2023 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 25,000 | $13.38 | $334,500.00 | -1.4% | -19.3% | -56.2% | |
| Nov 30, 2023 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 25,000 | $12.57 | $314,250.00 | -2.6% | -7.0% | -27.5% | |
| Nov 22, 2023 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 8,181 | $14.39 | $117,740.22 | -0.4% | +4.3% | -42.8% | |
| Nov 2, 2023 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 30,000 | $12.65 | $379,450.00 | -1.6% | -17.2% | -26.2% | |
| Sep 29, 2023 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 25,000 | $12.41 | $310,250.00 | -2.5% | +17.3% | -1.3% | |
| Sep 5, 2023 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 25,000 | $10.26 | $256,600.00 | -1.2% | +20.3% | -9.7% | |
| Aug 16, 2023 | OLMA Olema Pharmaceuticals, Inc. | Director | Sell | 15,000 | $10.14 | $152,100.00 | -1.4% | +66.8% | +30.1% |